Temple Health’s Excellence in Health Equity: CBS3 Segment on Peripartum Cardiomyopathy Features Dr. Deborah Crabbe, Patient and Son; Highlights Temple’s Participation in National REBIRTH Clinical Trial

A CBS3 segment on peripartum cardiomyopathy featured Deborah L. Crabbe, MD, FACC, FAHA, Professor of Medicine at the Lewis Katz School of Medicine at Temple University; patient Chelsi Svenson-Boyce; and her son Jaxson. Peripartum cardiomyopathy, or PPCM, is a rare, complex heart condition that occurs between the last month of pregnancy and 5 months after delivery and can lead to heart failure. PPCM is more commonly seen in African-American women. Temple is participating in the national REBIRTH clinical trial to investigate medical treatment for PPCM. The trial started after Chelsi was diagnosed with her condition.